Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,516
Total Claims
$912K
Drug Cost
1,214
Beneficiaries
$751
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+40%
Opioid rate vs peers
64.3% vs 45.9% avg
+56%
Cost per patient vs peers
$751 vs $483 avg
+74%
Brand preference vs peers
7.2% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
64.3%
Opioid Rate
4,836
Opioid Claims
$610K
Opioid Cost
16.0%
Long-Acting Rate
This provider's opioid prescribing rate of 64.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 539 claims · $478K
Generic: 6,977 claims · $434K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 37 | $178K |
| Oxycodone Myristate | 141 | $148K |
| Methylnaltrexone Bromide | 36 | $89K |
| Oxycodone Hcl/Acetaminophen | 2,097 | $86K |
| Oxycodone Hcl | 87 | $80K |
| Lidocaine | 66 | $56K |
| Diclofenac Sodium | 224 | $26K |
| Naloxegol Oxalate | 51 | $23K |
| Hydrocodone/Acetaminophen | 593 | $20K |
| Oxycodone Hcl | 762 | $19K |
| Lidocaine | 108 | $19K |
| Fentanyl | 121 | $12K |
| Morphine Sulfate | 278 | $9,541 |
| Pregabalin | 254 | $9,377 |
| Gabapentin | 571 | $8,534 |
Prescribing Profile
38
Unique Drugs
21.0
Anomaly Score
Patient Profile
68
Avg Age
58%
Female
2.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About